SCOTCERV: A phase II trial of docetaxel and gemcitabine as second-line chemotherapy in cervical cancer

被引：0
|
作者：
Symonds, R.
Davidson, S.
Chan, S.
Reed, N.
McMahon, T.
Paul, J.
机构：
[1] Univ Leicester, Leicester, Leics, England
[2] Christie Hosp, Manchester, Lancs, England
[3] City Hosp, Nottingham, England
[4] Beatson Oncol Ctr, Glasgow, Lanark, Scotland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5548
引用
收藏
页数：1
相关论文
共 50 条
  • [1] SCOTCERV: A phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer
    Symonds, R. P.
    Davidson, S. E.
    Chan, S.
    Reed, N. S.
    McMahon, T.
    Rai, D.
    Harden, S.
    Paul, J.
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 123 (01) : 105 - 109
  • [2] Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial
    Spiridonidis, CH
    Laufman, LR
    Carman, L
    Moore, T
    Blair, S
    Jones, J
    George, C
    Patel, T
    Roach, R
    Rupert, R
    Zangmeister, J
    Colborn, D
    Kuebler, JP
    [J]. ANNALS OF ONCOLOGY, 2001, 12 (01) : 89 - 94
  • [3] A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer
    Martina Baur
    Allan T. van Oosterom
    Véronique Diéras
    Michele Tubiana-Hulin
    R. Charles Coombes
    Thomas Hatschek
    Michael Murawsky
    May Klink-Alakl
    Marcus Hudec
    Christian Dittrich
    [J]. Journal of Cancer Research and Clinical Oncology, 2008, 134 : 125 - 135
  • [4] A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer
    Baur, Martina
    van Oosterom, Allan T.
    Dieras, Veronique
    Tubiana-Hulin, Michele
    Coombes, R. Charles
    Hatschek, Thomas
    Murawsky, Michael
    Klink-Alakl, May
    Hudec, Marcus
    Dittrich, Christian
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (02) : 125 - 135
  • [5] A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer
    Sculier, JP
    Lafitte, JJ
    Berghmans, T
    Thiriaux, J
    Lecomte, J
    Efremidis, A
    Ninane, V
    Paesmans, M
    Mommen, P
    Klastersky, J
    [J]. LUNG CANCER, 2000, 29 (01) : 67 - 73
  • [6] Gemcitabine plus paclitaxel and gemcitabine plus docetaxel in first- or second-line metastatic breast cancer: A phase II randomized trial
    Boccia, R. V.
    Vaughn, L.
    Zeigler, H.
    Wang, Y.
    Gill, J.
    Melemed, A.
    Shonukan, O.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Weekly docetaxel as second-line chemotherapy in advanced non-small cell lung cancer: Phase II trial
    Serke, M
    Schoenfeld, N
    Loddenkemper, R
    [J]. ANTICANCER RESEARCH, 2004, 24 (2C) : 1211 - 1216
  • [8] Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer:: a multicenter phase II trial
    Boeck, S.
    Weigang-Koehler, K.
    Fuchs, M.
    Kettner, E.
    Quietzsch, D.
    Trojan, J.
    Stoetzer, O.
    Zeuzem, S.
    Lordick, F.
    Koehne, C. -H.
    Kroening, H.
    Steinmetz, T.
    Depenbrock, H.
    Heinemann, V.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (04) : 745 - 751
  • [9] Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial
    Niho, S
    Kubota, K
    Goto, K
    Ohmatsu, H
    Matsumoto, T
    Kakinuma, R
    Nishiwaki, Y
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (01) : 19 - 24
  • [10] Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial
    Seiji Niho
    Kaoru Kubota
    Koichi Goto
    Hironobu Ohmatsu
    Taketoshi Matsumoto
    Ryutaro Kakinuma
    Yutaka Nishiwaki
    [J]. Cancer Chemotherapy and Pharmacology, 2003, 52 : 19 - 24
12345